HIV Medical Providers Call for Fair Drug Pricing to Expand Access to Treatment

Practitioners from the American Academy of HIV Medicine (AAHIVM) and the HIV Medicine Association (HIVMA) delivered a joint statement to pharmaceutical company executives this week, asking the industry to reconsider its pricing for antiretroviral drugs so that more people in the U.S. and worldwide are able to access treatment.

Read more:

Activists Focus on Budget Cuts for World AIDS Day

On the eve of the 25th observance of World AIDS Day, people with HIV and those at risk are well positioned to benefit from recent medical advances, but they also face some sobering political and fiscal realities.

The election of Barack Obama to a second term as president brought relief that the Affordable Care Act -- his hard-won health insurance reform package -- would not be immediately overturned. But its implementation remains a challenge, and the looming "fiscal cliff" threatens budget cuts across the board.

Read more:

Young Adults Account for One-quarter of New U.S. HIV Cases, Majority Not Aware of Status

Adolescents and young adults between the ages of 13 and 24 account for 26% of new annual HIV infections in the U.S. -- with young gay/bisexual men and African-Americans most heavily affected -- but 60% do not know they are HIV positive, according to the latest Vital Signs report from the Centers for Disease Control and Prevention (CDC).

Read more:

UNAIDS Reports Progress, PEPFAR Blueprint Looks Towards AIDS-free Generation

The latest global report from UNAIDS, release ahead of World AIDS Day on December 1, highlights progress in stemming the epidemic, including lower rates of new infection in many countries and a growing proportion of HIV positive people on antiretroviral treatment. Continued progress requires adequate funding, however. To that end, U.S. Secretary of State Hillary Clinton this week released a "Blueprint" detailing recent advances and future plans for achieving a generation free from AIDS.

Read more: